Skip to main content

Applied Biosystems Will Use AnVil Systems To Find Predicted Genes

NEW YORK, June 12-AnVil and Applied Biosystems will work together on a gene validation project that seeks to verify genes that have been predicted but not yet identified.


AnVil will apply its visualization and analysis tools to the database of human genome information developed by Celera Genomics that is now held by Applied Biosystems.


The project seeks to resolve how many of these potential genes are actual coding regions, potentially providing new insight into the total number of human genes.


"All signs seem to indicate that these genes exist, but there is not enough information to be conclusive," said AnVil marketing director William Wiegler. "ABI is looking for additional tools and expertise to analyze the data and come to more conclusive results. That's where we fit in."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.